Behavioral Trial for the Treatment of Methamphetamine Dependence

National Institute on Drug Abuse (NIDA)5 sites in 1 country50 target enrollmentJuly 2001

ConditionsSubstance-Related Disorders

Overview

Phase: Phase 2
Intervention: Not specified
Conditions: Substance-Related Disorders
Sponsor: National Institute on Drug Abuse (NIDA)
Enrollment: 50
Locations: 5
Primary Endpoint: Withdrawal symptoms
Last Updated: 9 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to examine behavioral treatment for methamphetamine dependence.

Detailed Description

To characterize meth. withdrawal symptoms using a multidimensional withdrawal questionnaire; to field test and investigate the effect of using an algorithm developed for discriminating between new use and residual carry-over of meth metabolites in urine and to evaluate the treatment response of meth. users to participation in the thrice weekly psychosocial protocol to be used as a "platform" in future pharmacotherapy trials.

Registry

clinicaltrials.gov

Start Date

July 2001

End Date

June 2002

Last Updated

9 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

National Institute on Drug Abuse (NIDA)

Eligibility Criteria

Inclusion Criteria

•Male or Female at least 18 yrs of age; DSM-4 diagnosis of methamphetamine (METH) dependence; be willing to comply with study procedures; verbalize understanding of consent and provide written consent and willingness to complete study procedures; be seeking treatment for METH dependence.